Valeant to be led by group of senior execs as CEO on medical leave
[BENGALURU] Valeant Pharmaceuticals International Inc said a group of company executives will take over in an interim capacity, until CEO Michael Pearson returns from medical leave.
Pearson will be on a medical leave of absence, effective immediately, the company said in a statement on Monday.
Pearson was hospitalized with a "severe case of pneumonia"on Friday and is receiving treatment, a company spokeswoman said on Friday.
Valeant's board has created an "office of the Chief Executive Officer", which will include general counsel Robert Chai-Onn, company group chairman Ari Kellen, and chief financial officer Robert Rosiello.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
US Justice Department to seek breakup of Live Nation-Ticketmaster
Disney to sell stake in Tata’s US$1 billion India TV platform: sources
LVMH deepens partnership with Alibaba to boost tech presence in China
Chanel nears US$20 billion in sales in 2023
Chanel to open more stores in China even as growth shifts abroad
China’s JD.com aims to raise US$1.5 billion in convertible bond deal